Companies in
Pharmaceutical Industry

GE Healthcare AG

Pharmaceutical Industry · Glattbrugg · Since 2000

GE Healthcare AG is a medical technology company that provides imaging systems and modalities including ultrasound, CT, MRI, mammography and molecular imaging. It also supplies contrast media and nuclear imaging agents, patient monitoring and perioperative solutions, healthcare IT and digital services, alongside lifecycle services such as maintenance, predictive services, cybersecurity and financing.

Genpax SA

Pharmaceutical Industry · Gsteig B. Gstaad · Since 2020

Genpax SA provides an automated whole genome sequencing (WGS) analysis platform to identify bacterial pathogens and antimicrobial resistance and to generate comparable data across sites. The IDEM platform supports use in healthcare, public health, One Health and research settings.

Gigabases Switzerland AG

Research & Development · Reinach Bl · Since 2018

Gigabases Switzerland AG operates a web-based platform for 3D protein design and ordering sequence-verified expression plasmids. The platform provides a database of over 214 million protein 3D structures, tools to modify proteins at the amino-acid level, and algorithms that translate designs into ready-to-order plasmids for mammalian, viral, or bacterial expression.

Gilead Sciences Switzerland Sàrl

Pharmaceutical Industry · Zug · Since 2006

The core activity of Gilead is the development and manufacture of pharmaceuticals, particularly for the treatment of severe and life-threatening diseases such as HIV, liver diseases and cancer.

Gimmune GmbH

Pharmaceutical Industry · Zug · Since 2008

The core activity of Gimmune GmbH is the development and production of innovative medical products, particularly: Anti-cancer and anti-viral compounds, Anti-glycan antibodies, Nano-devices for single-cell analysis, Monoclonal antibodies, especially Anti-glyconectin antibodies. The company focuses on research and development (R&D) in the fields of oncology and virology and offers products and services in these areas.

GlaxoSmithKline AG Zweigniederlassung Baar/Zug

Pharmaceutical Industry · Baar · Since 2019

GlaxoSmithKline AG Zweigniederlassung Baar/Zug is a branch of the biopharmaceutical company GSK, engaged in research, development and commercialization of medicines, vaccines and healthcare products, with R&D focused on respiratory, immunology and inflammation, oncology, HIV and infectious diseases.

Gliapharm SA

Pharmaceutical Industry · Geneva · Since 2017

Gliapharm SA develops medicines that target glial cells to enhance brain energy metabolism and support neuronal function. The company uses its GliaX™ discovery platform to identify molecular targets and small‑molecule candidates and advances preclinical translational models and biomarkers.

Global Pharmacare AG

Pharmaceutical Industry · Basel · Since 2006

Global Pharmacare AG provides services for the pharmaceutical sector, including sourcing new molecules, technology transfer for formulation technologies, and development of custom pellet-based delivery systems. Its services also include preparing registration documentation, supporting regulatory submissions, providing financial support, arranging factory audits, and handling distribution and logistics for diagnostic and pharmaceutical products.

GlycoEra AG

Pharmaceutical Industry · Wädenswil · Since 2020

The core activity of GlycoEra is the development of innovative biologics based on a glycoengineering platform, particularly for the treatment of autoimmune diseases and neurological disorders through protein degradation.

Gonadosan GmbH

Pharmaceutical Industry · St. Gallen · Since 2009

Gonadosan GmbH markets the Fertilovit brand of dietary supplements that support fertility, pregnancy and breastfeeding. The product range includes targeted formulations for women and men, including preparations for PCOS, Hashimoto, endometriosis and limited semen quality.

Granite Bio AG

Pharmaceutical Industry · Basel · Since 2021

Granite Bio AG is a biotechnology company developing first-in-class therapeutic antibodies for inflammatory, autoimmune and fibrotic diseases. Its pipeline includes GRT-001, an antibody that depletes pro-inflammatory monocytes and is in Phase 1b for inflammatory bowel disease, and GRT-002, an interleukin-3–blocking antibody in preclinical development expected to enter clinical trials in 2026.

Green Gold Health SA

Pharmaceutical Industry · Puidoux · Since 2019

The company's core activity encompasses the production and distribution of: 1. Pharmaceutical products, including accessible and affordable medications, anesthetics (e.g. Propofol) and medicines for the treatment of Covid-19. 2. CBD cosmetics and supplements, including creams, oils and water-soluble CBD products designed for skin health and overall well-being. 3. Innovative supplements, such as sports nutrition supplements, anti-hangover pills and supplements for the prevention of Covid-19. 4. In-vitro diagnostics, including PCR tests, antigen tests and devices for the diagnosis of Covid-19 infections. The company operates globally and has subsidiaries in Switzerland, Spain, Hong Kong and China.

GRG Gene Technology SA

Research & Development · Contone · Since 2014

The core activity of GRG Gene Technology is the development of innovative therapeutic strategies for cardiovascular diseases through the application of plant biotechnology to human health. In particular, the company focuses on the development of anti-atherogenic APOA-1 mutants that can be administered in a safe and cost-effective manner to deliver optimal doses of the active ingredient.

Grow Motion AG

Research & Development · Zuchwil · Since 2020

Grow Motion AG cultivates and supplies medical cannabis and CBD products. The company operates an indoor production facility following a 'seed to sell' approach with controlled cultivation, drying and quality-control processes. Offerings include CBD oils and CBD flower, sold via its online shop and to wholesale customers.

Grünenthal Pharma AG

Pharmaceutical Industry · Mitlödi · Since 1993

Grünenthal Pharma AG is a pharmaceutical company focused on research and the marketing of prescription medicines for pain and inflammatory conditions. The Swiss subsidiary manages commercialization of products from group R&D and from licensing partnerships; the group in Switzerland also includes production and trading entities such as Proto Chemicals AG (active substance manufacturing) and Protopharm AG (pharmaceutical trading).

GT Gain Therapeutics SA

Research & Development · Lugano · Since 2024

The company is active in the field of biopharmaceuticals (bio-pharma).

Guerbet Imaging Switzerland AG

Pharmaceutical Industry · Zug · Since 2013

HAB Invest AG

Pharmaceutical Industry · Lucerne · Since 2009

The core activity of HAB Invest AG is the development, manufacture and distribution of medical products and pharmaceuticals.

Haleon CH SARL

Pharmaceutical Industry · Prangins · Since 1991

Hans Rentsch AG

Pharmaceutical Industry · Speicher · Since 1978

The core activity of Hans Rentsch AG is the distribution of naturopathic medicinal products, including phytotherapeutic agents, homeopathic remedies and dietary supplements, for complementary medicine.

Hartis-Pharma SA

Pharmaceutical Industry · Nyon · Since 2018

The core activity of HARTIS Pharma consists of researching and developing therapeutics based on the potential benefits of High-Density-Lipoprotein (HDL), particularly through the regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants. The company focuses on developing treatments for medical needs that have not been adequately addressed or cannot be treated sufficiently.

Haut-Lac Ecole Internationale Bilingue SA

Pharmaceutical Industry · St-Légier-La Chiésaz · Since 2003

Thermo Fisher Scientific is a leading company in the life science industry, specializing in the development, manufacture and distribution of products and services for research, development and production of pharmaceuticals, biotechnology and environmental analysis. The company's core activities include research and development, manufacturing of laboratory equipment and supplies, diagnostics, pharmaceutical development and production, as well as environmental analysis.

Haya Therapeutics SA

Pharmaceutical Industry · Epalinges · Since 2019

The company develops precise therapeutics based on genome research and biotechnology. It focuses on the development of medicines and therapies, particularly in the field of cardiovascular diseases and regenerative medicine. The core activity includes research and development of new medicines, identification and evaluation of new business opportunities, conducting due diligence reviews, and managing portfolio companies.

Healiva SA

Pharmaceutical Industry · Lugano · Since 2024

Healiva SA is a patient‑centric biotech company developing personalized therapies for chronic wound care. It combines cell therapies, enzyme technology and medical devices and is developing products such as EpiDex (epidermal cell graft), AQUAtryp (enzymatic debriding agent), Healiva 002 (allogeneic cell spray) and Healiva 004 (autologous blood patch) for hard‑to‑heal wounds.

HealthWatch Swiss AG

Pharmaceutical Industry · Baar · Since 2007

The core activity of HealthWatch Swiss is the development, licensing and marketing of pharmaceuticals, particularly through strategic partnerships and licenses, to provide patients with access to high-quality medications while simultaneously opening up new business areas to ensure sustainable growth.

HEKETISS SA

Pharmaceutical Industry · Plan-Les-Ouates · Since 2021

The core activity of HekeTiss is the development and marketing of innovative therapies for the treatment of chronic wounds, particularly through the use of stem cells derived from adipose tissue. The company focuses on the development of skin substitute products, such as TrophiPatch, a cell-based skin patch that promotes wound healing through the angiogenic and regenerative properties of stem cells.

Helvepharm AG

Pharmaceutical Industry · Frauenfeld · Since 2001

The core activity of Zentiva is the development, production and marketing of generics, i.e. cost-effective copycat medicines, in various therapeutic areas, including oncology.

Helvetica-Pharm GmbH

Pharmaceutical Industry · Arbon · Since 2018

The core activity of Helvetica Pharm is the development, manufacture and marketing of sustainable biological products, in particular those based on natural ingredients that can be used for the prevention or treatment of diseases.

Helvetic Pharma AG

Pharmaceutical Industry · Schenkon · Since 2020

The core activity of Helvetic Pharma AG is the development, manufacture and distribution of dietary supplements, vitamins and minerals with the highest bioavailability. The company uses a patented micellization process to produce products with nearly 100% bioavailability. The distribution of the products takes place exclusively on the Swiss market and in Liechtenstein.

Helvion Pharma AG

Pharmaceutical Industry · Zug · Since 2024

Hempcare GmbH

Farm Shops & Farms · Wangen Sz · Since 2024

The core activity of Swiss HempCare is the production and distribution of products made from the medicinal plant Cannabis Sativa L., particularly CBD products. The company focuses on the development and production of high-quality core products tailored to the needs of its customers.

Herbamed AG

Pharmaceutical Industry · St. Gallen · Since 1983

Herbamed AG manufactures herbal mother tinctures, homeopathic remedies and pharmaceuticals, offering around 600 tinctures in its standard range produced according to the general requirements of the Homoeopathic Pharmacopoeia. The company also produces dilutions, triturations and globules (including veterinary medicines) and provides contract manufacturing and documentation services.

Herbonis AG

Pharmaceutical Industry · Augst Bl · Since 2004

Herb-pharma AG

Cosmetics Industry · Zurich · Since 2008

The core activity of Herb-Pharma is the development, manufacture and marketing of cosmetic products, dietary supplements and pharmaceuticals based on natural ingredients and biotechnological products. The company focuses particularly on skin care and develops innovative products based on scientific findings and sustainable natural resources.

HetCat PD Dr. Reza Fallahpour

Chemical Industry · Basel · Since 2005

HetCat PD Dr. Reza Fallahpour is a chemical services provider supplying heterocyclic and aromatic intermediates, metal catalysts, ligands and inorganic salts through an extensive product catalog. The company also offers custom synthesis and contract research from mg to kg scale, including process development, scale‑up and logistics support.

HGE-CH GmbH

Cosmetics Industry · Brügg Be · Since 2020

HGE-CH GmbH markets Olaris full-spectrum hemp extracts offered as tinctures in MCT carrier oil. The products are presented as cosmetics for skin care, manufactured in Switzerland, and accompanied by external laboratory analysis certificates available per product.

HISTIDE AG

Research & Development · Schindellegi · Since 2014

The core activity of Histide AG is the development and marketing of biotechnological products, in particular so-called Cell Recoding Molecules (CRM), which are intended for the treatment of rare diseases and tissue regeneration. The company focuses on the research and development of non-mutagenic extracellular therapeutic agents and has a strong patent and technology platform.

Hokochemie GmbH

Pharmaceutical Industry · Weggis · Since 1994

Hokochemie is a manufacturer of generics, particularly in the field of Life Sciences. The company's core activities include the development and production of products for public health, animal health, and human health. The company offers a wide range of products, including specific solutions such as Hokoex Fly Control, an insecticide for controlling flies.

Holistic Health Swiss AG

Cosmetics Industry · Zug · Since 2023

The core activity of Holistic Health Swiss AG is the development, manufacture and marketing of natural dietary supplements and health products, in particular plant-based formulations aimed at supporting the immune system, energy and holistic health.

Horus Pharma Suisse SA

Pharmaceutical Industry · Nyon · Since 2021

The core activity of Horus Pharma is the development, manufacture and marketing of pharmaceuticals, medical devices and dietary supplements, particularly in the fields of ophthalmology, dermatology and surgery. The company focuses on creating therapeutic solutions and accompanying services for doctors and patients, with an emphasis on innovation, ethics and patient benefit.

HRA-Pharma Switzerland Sàrl

Pharmaceutical Industry · Nyon · Since 2009

Humabs BioMed SA

Research & Development · Bellinzona · Since 2024

The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.

Hylamed Surgical AG

Medical Technology Industry · Egg B. Zürich · Since 2006

IBSA Institut Biochimique SA

Pharmaceutical Industry · Pazzallo · Since 1945

IBSA Institut Biochimique SA is a multinational pharmaceutical company that develops, manufactures and commercializes medicinal products. Its portfolio covers therapeutic areas including reproductive medicine, endocrinology, pain and inflammation, osteo‑articular conditions, aesthetic medicine, dermatology, uro‑gynecology, cardiometabolic and respiratory diseases and consumer health, and includes hyaluronic acid–based products as well as pharmaceutical formulations and delivery systems.

ICON Clinical Research (Switzerland) GmbH

Pharmaceutical Industry · Basel · Since 1998

The company ICON is a service provider to the pharmaceutical industry, focusing on clinical research, medical communication, and market access. The core activities include: * Clinical Research: Conducting clinical trials, including decentralized clinical trials, early-phase studies, and bioanalysis * Medical Communication: Creating medical content, such as publications, presentations, and marketing materials * Market Access: Supporting pharmaceutical companies in launching medicines, including health economics, outcomes research, and market research * Laboratory Services: Bioanalysis, biomarker development and analysis, as well as other laboratory services * Consulting: Strategic consulting for pharmaceutical companies in the areas of clinical research, market access, and medical communication The company also offers specialized services such as risk management, safety reporting, and regulatory affairs.

iGreen Swiss SA

Pharmaceutical Industry · Henniez · Since 2017

The core activity of iGreen Swiss S.A. is the development, production and distribution of medical cannabis and its derived products, in particular Tetrahydrocannabinol (THC) and Cannabidiol (CBD), for therapeutic purposes. The company is active in all phases of the value chain, from research and development to the manufacture and marketing of medical cannabis and its derived products.

IMCD Switzerland AG

Pharmaceutical Industry · Zurich · Since 1957

IMCD is a distributor and service provider for the chemical and pharmaceutical industries. The company's core activity is to create value for its business partners by offering a wide range of services, including distribution, marketing, technical support, and formulation. IMCD supports its customers in achieving their sustainability goals and provides consulting and technical support in implementing new solutions. The company has a global network and supports its customers across various industries.